Review of Myopia Management

01/09/2026

At the Global Specialty Lens Symposium (GSLS), CooperVision shared new insights regarding myopia control contact lenses.

“Lens Preference and Visual Performance of Two Myopia Control Contact Lenses” (Chang P, et al) evaluated how different zonal designs were perceived by children with myopia ages 8 to 15 years with no contact lens wearing experience (n=26).

Read the full announcement here: https://reviewofmm.com/coopervision-presents-myopia-control-contact-lens-insights-at-gsls/

CooperVision has presented new research on myopia control contact lens insights at the Global Specialty Lens Symposium.

01/09/2026

Visioneering Technologies, Inc. (VTI) shared the latest findings and clinical insights from its ongoing PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study.

The findings emphasize that NaturalVue Multifocals are designed to support myopia management in real-world pediatric populations.

Learn more here: https://reviewofmm.com/naturalvue-multifocals-reduces-myopia-risks/

New data presented at GSLS highlights NaturalVue Multifocal's ability to reduce myopia risks among children treated.

01/08/2026

CooperVision has announced a new myopia control contact lens, the MyDay MiSight 1 day contact lenses.

The new myopia treatment will be launching in the U.K. and select European and surrounding markets, expanding the company’s evidence-based myopia management portfolio. This new myopia control soft contact lens combines the proven MiSight 1 day ActivControl Technology with the advanced silicone hydrogel material used in MyDay lenses.

Read the full announcement here:
https://reviewofmm.com/myday-misight-1-day-myopia-control-soft-contact-lenses/

CooperVision has announced the launch of the MyDay MiSight 1 day myopia control soft contact lenses in the U.K. and European markets.

01/08/2026

Euclid Vision Corporation has announced the launch of Be Free Day Lens, a new silicone hydrogel daily disposable innovated to support a practitioner’s myopia management portfolio.

Read the full announcement here:
https://reviewofmm.com/euclid-announces-new-daily-disposal-silicone-hydrogel-lens-for-myopia-management/

Euclid Vision Corporation announced the launch of Be Free Day, a new silicone hydrogel daily disposable contact lens for myopia management.

01/04/2026

Have you used the holiday season to recommit to myopia management?

Before the hustle and bustle picks up again, learn how to make the most of your myopia management offerings: https://reviewofmm.com/the-holiday-pause-recommitment-in-myopia-care/

This month, Medical Co-Editor Dr. Ashley Tucker shares how the holiday season presents the perfect time to pause and reflect in eye care.

01/04/2026

A successful myopia management practice isn't just about the technology—it’s about the culture.

Ensuring your staff shares your passion is the #1 way to build trust with parents.

When the front desk and technicians understand that every millimeter of axial length saved protects a child’s future vision, the patient experience transforms.

Learn more: https://reviewofmm.com/an-all-in-myopia-management-practice/

Beyond Eyecare

Dr. Sami Khaldieh shares how to make your myopia management practice stronger than ever from every aspect.

01/03/2026

Is low-level red-light therapy (LLLT) the most potent tool in our kit?

The IMI 2025 update highlights LLLT as a powerhouse intervention, showing axial elongation reductions of up to 0.40mm in a single year.

However, the report also urges caution regarding long-term safety and potential rebound effects. It’s a fascinating frontier that requires a balanced clinical approach.

Read more here: https://reviewofmm.com/imi-interventions-for-controlling-myopia-onset-and-progression-2025/


International Myopia Institute

In this Research Review, Dr. Ashley Tucker explores the IMI white paper that breaks down safety and efficacy of myopia interventions.

01/03/2026

Since myopia management emerged as an eye care subspecialty, treatments have mainly fallen into the “off-label” category. However, this has begun to change over the past few years.

In this article, Dwight Barnes, OD, FIAOMC, IACMM explore the history of FDA approval related to myopia management options and how to best address parental concerns regarding the FDA approval status of these crucial treatments: https://reviewofmm.com/addressing-parental-concerns-regarding-off-label-treatments/


Cary Family Eye Care

Dr. Dwight Barnes wrote about how ECPs can talk to parents about prescribing off-label treatments for myopia management.

01/02/2026

How do you go about prescribing combination therapy to your myopia patients?

Tina Douroudian, OD, shared her protocol for combination treatments here:https://reviewofmm.com/a-practical-approach-to-combination-therapy/

Dr. Tina Douroudian shares the protocol she's created for initiating combination therapy in her young myopic patients.

01/02/2026

Earlier this year, Philip Cheng, B.Optom (Melb), GCOT, IACMM, FIAOMC shared his experience at the Shanghai International Optical Fair, including the myopia spectacle lenses that are being developed around the world.

Read the full story here: https://reviewofmm.com/the-proliferation-of-myopia-management-spectacles/



The University of Melbourne Myopia Clinic - Melbourne Australia

Dr. Philip Cheng shared his international experience with myopia management spectacles and what ECPs can expect in years to come.

12/31/2025

12/31/2025

Now that our countdown is over, what was YOUR favorite Review of Myopia Management story in 2025?

Share your favorites below!